PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2539

  1. 502 Posts.
    lightbulb Created with Sketch. 143
    I believe in facts and the evidence submitted in research reports and presentations.
    Coincidently this plays a significant factor in the companies I invest in, which is why I am here.
    I politely asked you to point me to the evidence you quoted for my research.
    It was a simple request, and as you repeat it so often, I thought it was a printed fact.
    As I look at your previous posts, I see where you got your information.
    It is shady territory divulging details from a private conversation on an investing forum to potential trial subjects before the study's conclusion.
    The placebo effect is triggered by a person's belief in the benefit from the treatment and their expectation of feeling better.
    These professionals are running a randomised DBPC trial while you're interfering with the potential test subject's expectations.
    There is a 50% chance participants will receive the placebo, so you're already complicating things.
    Good day, sir.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.80M
Open High Low Value Volume
28.0¢ 29.0¢ 24.0¢ $969.3K 3.648M

Buyers (Bids)

No. Vol. Price($)
6 34182 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 24689 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.